Expectant versus aggressive management in severe preeclampsia remote from term.
BACKGROUND
Our study aims to compare neonatal and maternal outcomes between expectant (or conservative) and aggressive (or immediate) management in cases with severe preclampsia remote from term.


METHODS
This is a comparative study conducted at Al-Batool Teaching Hospital in Mosul City, Iraq, from April 2003 to August 2004. A total of 74 singleton pregnancies complicated by severe preeclampsia with gestational age of 24-34 weeks were studied during this period. The criteria used for the diagnosis of severe preeclampsia were in accordance with the guidelines of the American College of Obstetricians and Gynaecologists. All the patients were counselled for expectant management. 39 patients were delivered immediately due to refusal of expectant management either by the patient or the attending physician. The other 35 patients were managed expectantly; this group was followed-up and carefully monitored for a period ranging from 72 hours to 18 days. Neonatal parameters, neonatal outcome and maternal outcome were compared between the two groups.


RESULTS
The mean value of pregnancy prolongation was 9.2 days. Median gestational age for the first group was 29 weeks, and for the second group, it was 30 weeks. Regarding neonatal parameters, the expectantly-managed group had a higher Apgar score at one minute (3.56 +/- 1.72 vs. 5.05 +/- 1.77, p-value equals 0.001), lower mean days of hospitalisation in the neonatal intensive care unit (6.83 +/- 5.38 vs. 4.50 +/- 3.46, p-value equals 0.03), with a lower incidence of neonatal and maternal complications.


CONCLUSIONS
Expectant management is recommended in patients with severe preeclampsia remote from term, after proper selection of patients and careful monitoring.
Sarsam
D S
DS
Department of Obstetrics and Gynaecology, Al-Kindy Medical College, Baghdad University, Baghdad, Iraq. samarsarsam4@yahoo.com
Shamden
M
M
Al Wazan
R
R
D001724:Birth Weight; D036861:Delivery, Obstetric; D005260:Female; D005865:Gestational Age; D017359:HELLP Syndrome / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007493:Iraq; D015997:Neonatal Screening; D009774:Obstetrics / Q000379:methods*; D011225:Pre-Eclampsia / Q000175:diagnosis* / Q000188:drug therapy*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000188:drug therapy; D011256:Pregnancy Outcome